QURE – uniQure N.V.
uniQure N.V.QURE
$13.70Name : uniQure N.V.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $751,402,176.00
EPSttm : -3.9
uniQure N.V.
$13.70
1.62%$0.225Float Short %
17.36
Margin Of Safety %
Put/Call OI Ratio
0.17
EPS Next Q Diff
0.03
EPS Last/This Y
2.2
EPS This/Next Y
0.2
Price
13.69
Target Price
34.33
Analyst Recom
1.29
Performance Q
-8.7
Relative Volume
0.69
Beta
0.1
Ticker: QURE
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-04 | QURE | 14.42 | 0.22 | 0.15 | 79516 |
| 2025-07-07 | QURE | 14.3 | 0.22 | 0.01 | 79589 |
| 2025-07-08 | QURE | 14.44 | 0.22 | 0.01 | 80349 |
| 2025-07-09 | QURE | 14.89 | 0.22 | 0.48 | 80570 |
| 2025-07-10 | QURE | 14.89 | 0.22 | 0.14 | 80780 |
| 2025-07-11 | QURE | 14.39 | 0.22 | 0.11 | 80784 |
| 2025-07-14 | QURE | 14.55 | 0.21 | 0.00 | 80792 |
| 2025-07-15 | QURE | 13.98 | 0.20 | 0.34 | 83343 |
| 2025-07-16 | QURE | 14.42 | 0.20 | 0.01 | 83379 |
| 2025-07-17 | QURE | 15.19 | 0.20 | 0.02 | 85572 |
| 2025-07-18 | QURE | 14.91 | 0.19 | 0.96 | 86990 |
| 2025-07-21 | QURE | 14.5 | 0.16 | 0.89 | 43509 |
| 2025-07-22 | QURE | 14.24 | 0.17 | 0.18 | 44122 |
| 2025-07-23 | QURE | 15.37 | 0.17 | 0.96 | 44947 |
| 2025-07-24 | QURE | 15.2 | 0.18 | 4.54 | 45982 |
| 2025-07-25 | QURE | 15.1 | 0.21 | 0.72 | 47358 |
| 2025-07-28 | QURE | 15 | 0.21 | 9.32 | 47687 |
| 2025-07-29 | QURE | 13.67 | 0.23 | 0.08 | 48846 |
| 2025-07-30 | QURE | 14.45 | 0.17 | 0.21 | 64242 |
| 2025-07-31 | QURE | 13.92 | 0.17 | 0.05 | 64509 |
| 2025-08-01 | QURE | 13.67 | 0.17 | 0.39 | 64595 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-04 | QURE | 14.42 | 28.9 | 32.7 | -2.99 |
| 2025-07-07 | QURE | 14.31 | 28.9 | 36.4 | -2.99 |
| 2025-07-08 | QURE | 14.44 | 28.9 | 32.9 | -2.99 |
| 2025-07-09 | QURE | 14.87 | 28.9 | 28.6 | -2.99 |
| 2025-07-10 | QURE | 14.88 | 28.9 | 34.6 | -2.99 |
| 2025-07-11 | QURE | 14.40 | 28.9 | 41.2 | -2.99 |
| 2025-07-14 | QURE | 14.55 | 28.9 | 32.6 | -2.99 |
| 2025-07-15 | QURE | 13.96 | 28.9 | 43.2 | -2.99 |
| 2025-07-16 | QURE | 14.41 | 28.9 | 27.8 | -2.99 |
| 2025-07-17 | QURE | 15.20 | 28.9 | 23.5 | -2.99 |
| 2025-07-18 | QURE | 15.00 | 28.9 | 37.3 | -2.99 |
| 2025-07-21 | QURE | 14.51 | 28.9 | 41.4 | -2.99 |
| 2025-07-22 | QURE | 14.24 | 28.9 | 38.5 | -2.99 |
| 2025-07-23 | QURE | 15.38 | 28.9 | 18.1 | -2.99 |
| 2025-07-24 | QURE | 15.21 | 28.9 | 36.9 | -2.99 |
| 2025-07-25 | QURE | 15.11 | 28.9 | 36.2 | -2.96 |
| 2025-07-28 | QURE | 15.00 | 29.4 | 36.2 | -2.96 |
| 2025-07-29 | QURE | 13.68 | 29.4 | 52.2 | -2.96 |
| 2025-07-30 | QURE | 14.46 | 29.4 | 23.3 | -2.96 |
| 2025-07-31 | QURE | 13.92 | 29.4 | 24.6 | -2.96 |
| 2025-08-01 | QURE | 13.69 | 8.8 | 20.7 | -2.72 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-04 | QURE | -2.29 | 32.79 | 15.45 |
| 2025-07-07 | QURE | -2.29 | 32.79 | 15.45 |
| 2025-07-08 | QURE | -2.30 | 32.79 | 15.45 |
| 2025-07-09 | QURE | -2.30 | 32.79 | 15.45 |
| 2025-07-10 | QURE | -2.30 | 32.79 | 15.45 |
| 2025-07-11 | QURE | -2.30 | 32.79 | 17.59 |
| 2025-07-14 | QURE | -2.30 | 32.77 | 17.59 |
| 2025-07-15 | QURE | -2.30 | 32.77 | 17.59 |
| 2025-07-16 | QURE | -2.30 | 32.77 | 17.59 |
| 2025-07-17 | QURE | -2.30 | 32.77 | 17.59 |
| 2025-07-18 | QURE | -2.30 | 32.77 | 17.59 |
| 2025-07-21 | QURE | -2.30 | 30.11 | 17.59 |
| 2025-07-22 | QURE | -2.30 | 30.11 | 17.59 |
| 2025-07-23 | QURE | -2.30 | 30.11 | 17.59 |
| 2025-07-24 | QURE | -2.30 | 30.11 | 17.59 |
| 2025-07-25 | QURE | -2.30 | 30.11 | 17.40 |
| 2025-07-28 | QURE | -2.30 | 29.53 | 17.40 |
| 2025-07-29 | QURE | -2.30 | 29.53 | 17.40 |
| 2025-07-30 | QURE | -2.30 | 29.53 | 17.40 |
| 2025-07-31 | QURE | -2.30 | 29.53 | 17.40 |
| 2025-08-01 | QURE | -2.29 | 29.53 | 17.36 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.69
Avg. EPS Est. Current Quarter
-0.76
Avg. EPS Est. Next Quarter
-0.66
Insider Transactions
-2.29
Institutional Transactions
29.53
Beta
0.1
Average Sales Estimate Current Quarter
4
Average Sales Estimate Next Quarter
14
Fair Value
Quality Score
24
Growth Score
36
Sentiment Score
11
Actual DrawDown %
73.8
Max Drawdown 5-Year %
-92.5
Target Price
34.33
P/E
Forward P/E
PEG
P/S
52.4
P/B
P/Free Cash Flow
EPS
-3.92
Average EPS Est. Cur. Y
-2.72
EPS Next Y. (Est.)
-2.53
Target Price Estimates Raised
Target Price Estimates Lowered
2
Profit Margin
-1387.98
Relative Volume
0.69
Return on Equity vs Sector %
Return on Equity vs Industry %
EPS 1 7Days Diff
0.2
EPS 1 30Days Diff
0.27
EBIT Estimation
20.7
uniQure N.V.Sector: Healthcare
Industry: Biotechnology
Employees: 209
uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial temporal lobe epilepsy; AMT-162, which is in Phase I/IIa clinical trial to treat superoxide dismutase enzyme-amyotrophic lateral sclerosis; and AMT-191, an investigational gene therapy candidate which is in phase I/IIa clinical trial for the treatment of fabry disease. It has a licensing agreement with Apic Bio to develop, manufacture, and commercialize intrathecally administered investigational gene therapy for ALS caused by mutations in SOD-1; and development and commercial supply agreement with CLS Bhering. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
stock quote shares QURE – uniQure N.V. Stock Price stock today
news today QURE – uniQure N.V. stock forecast ,stock prediction 2023 2024 2025
marketwatch QURE – uniQure N.V. yahoo finance google finance
stock history QURE – uniQure N.V. invest stock market
stock prices QURE premarket after hours
ticker QURE fair value insiders trading